Neurodegenerative Treatment Opportunities

Preparing for Growth in Neurodegenerative Treatment Opportunities

How clinical teams can best position study design and strategy to reach study participants

While patient enrollment and retention for clinical trials in this field can be challenging, CROs with the right expertise, tools and passion can help sponsors implement successful, cost-effective studies that minimize site and patient burden. This article covers:

  • Current clinical research in neuroscience
  • Complexity and challenges
  • Protocol optimization
  • Supported neurodegenerative disease clinical trials

Input from Alberto Lledó, M.D., Ph.D., Christine Martino, John Hamlet, and Sabine Krofczik-Wilhelm, Ph.D., PPD clinical research business of Thermo Fisher Scientific

PPD271_Neurodegenerative-Treatment-Opportunities article cover

Complete the form to read about growth in neurodegenerative treatment and how we support these clinical trials.